A new Inserm Transfert Technology Offers experience coming soon in April !

BIO14444-T1

ANTIBODIES SPECIFIC TO GLYCOPROTEIN (GP) OF EBOLAVIRUS AND USES FOR THE TREATMENT AND DIAGNOSIS OF EBOLA VIRUS INFECTION

The present invention relates to antibodies or fragments thereof that specifically bind to glycoprotein (GP) of Ebola virus, and to their use for treating and diagnosing Ebola virus disease.


Keywords : neutralizing monoclonal antibody
Patent Application number : EP15305348.3
Patent Application date : 2015-03-06
Multidisciplinary field : -
Technology/Engineering : Antibodies nanobodies
Technological Platform : -
Rare disease : -
Second indication : -
Inventors : Olivier REYNARD
Viktor VOLCHKOV
Publications :
  • J Infect Dis. 2015 Oct 1;212 Suppl 2:S372-8. doi: 10.1093/infdis/jiv303. Epub 2015 Aug 1.

Related offers


The 10 Last viewed

You haven't seen any form yet.